The Dow Jones Industrial Average increased by 150 points today, driven by gains in industrial and tech stocks amid ongoing economic concerns.
Browsing Category
Tax & Regulatory Guidance
102 posts
ECB To Extend Use Of Climate Factors In Eurosystem Collateral Framework To Non-financial Corporate Credit Claims
The ECB announced it will extend the use of climate considerations in its Eurosystem collateral framework to include non-financial corporate credit claims, aiming to promote sustainable finance.
VRRM Deadline: VRRM Investors With Losses In Excess Of $100K Have Opportunity To Lead Verra Mobility Corporation Securities Fraud Lawsuit
Investors in Verra Mobility (VRRM) with losses over $100K may now have the chance to participate in a securities fraud lawsuit, according to recent PR Newswire report.
EPR PROPERTIES Files 8-K: Material Agreement
EPR Properties has filed an 8-K with the SEC revealing a significant material agreement. Details are limited, with next steps yet to be announced.
Neuronata-R Retains Conditional Approval In South Korea
Neuronata-R retains conditional approval in South Korea, allowing continued clinical use amid ongoing review. Details on implications and next steps provided.
Trump Media Settles Legal Disputes
Trump Media has reached settlements in its ongoing legal disputes, ending multiple lawsuits. Details of the agreements have not been disclosed.
VivoSim Labs, INC. Files 8-K: Material Agreement
VivoSim Labs has filed an 8-K with the SEC revealing a material agreement, impacting its business operations and strategic direction.
Grand Bargain Project Announces Procedural Change That Will Turn Congress Into A Problem-Solving Institution Within Days
A new procedural change announced by the Grand Bargain Project aims to transform Congress into a problem-solving institution within days, according to PR Newswire.
Emission Von Bundesobligationen – Ankündigung Tenderverfahren
The German Bundesbank has announced a tender process for the issuance of federal bonds, signaling upcoming government debt management activities.
ADMA Investors Have Opportunity To Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed By The Rosen Law Firm
Investors in ADMA Biologics have the chance to lead a securities fraud lawsuit filed by The Rosen Law Firm, alleging misconduct by the company’s management.